SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
21-Feb-23 6:53 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 17-Feb-23 | Grant | 38,500 | -- | -- | 10% 378.93K to 417.43K | |
15-Feb-22 4:48 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 11-Feb-22 | Grant | 37,500 | -- | -- | 11% 341.43K to 378.93K | |
09-Sep-21 4:15 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 08-Sep-21 | Option Exercise | 11,000 | $4.30 | $47,300.00 | 3% 341.43K to 352.43K | |
09-Sep-21 4:15 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 08-Sep-21 | Market Option Sale (Planned) | 11,000 | $28.45 | $312,950.00 | (3%) 352.43K to 341.43K | |
26-Aug-21 7:11 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 10-Aug-21 | Option Exercise | 11,000 | $4.30 | $47,300.00 | 3% 341.43K to 352.43K | |
26-Aug-21 7:11 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 10-Aug-21 | Market Option Sale (Planned) | 11,000 | $27.00 | $297,000.00 | (3%) 352.43K to 341.43K | |
30-Dec-19 5:32 PM View: | Harpoon Therapeutics, Inc. (HARP) | 27-Dec-19 | Market Sale (Planned) | 87,379 | $15.98 | $1,396,280.00 | (25%) 349.51K to 262.14K | (19%) |
26-Dec-19 5:30 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 23-Dec-19 | Market Sale (Planned) | 84,907 | $15.44 | $1,310,960.00 | (19%) 435.69K to 350.79K | (24%) |
26-Dec-19 5:30 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 20-Dec-19 | Market Sale (Planned) | 32,022 | $15.16 | $485,454.00 | (7%) 467.71K to 435.69K | (27%) |
06-Mar-12 3:54 PM View: | Micromet, Inc. (MITI) | 02-Mar-12 | Disposition (change in control) | 16,266 | $11.00 | $178,926.00 | (100%) 16.27K to 0 | < 1% |
09-Mar-10 12:50 PM View: | Micromet, Inc. (MITI) | 11-Jun-09 | Private Sale | 6,297 | $5.52 | $34,759.40 | (28%) 22.56K to 16.27K | |
09-May-06 9:48 PM View: | Micromet, Inc. (MITI) | 05-May-06 | Grant | 22,563 | -- | -- | 100% 0 to 22.56K |